These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 138573)

  • 1. Acne treatment: a comparative efficacy trial of clindamycin and tetracycline.
    Panzer JD; Poche W; Meek TJ; Derbes VJ; Atkinson W
    Cutis; 1977 Jan; 19(1):109-11. PubMed ID: 138573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
    Braathen LR
    Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
    Bran EL; Robledo Aguilar A
    Med Cutan Ibero Lat Am; 1986; 14(6):433-42. PubMed ID: 2951570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin vs placebo as adjunctive therapy in moderately severe acne.
    Christian GL; Krueger GG
    Arch Dermatol; 1975 Aug; 111(8):997-1000. PubMed ID: 134670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
    Stoughton RB; Cornell RC; Gange RW; Walter JF
    Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
    Katsambas A; Towarky AA; Stratigos J
    Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne].
    Perez M; Aspiolea F; De Moragas JM
    Med Cutan Ibero Lat Am; 1987; 15(3):173-7. PubMed ID: 2959827
    [No Abstract]   [Full Text] [Related]  

  • 9. Acne vulgaris: double-blind trial comparing tetracycline and clindamycin.
    Poulos ET; Tedesco FJ
    Arch Dermatol; 1976 Jul; 112(7):974-6. PubMed ID: 132902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clindamycin as an alternative to tetracycline in severe acne vulgaris.
    Cunliffe WJ; Cotterill JA
    Practitioner; 1973 May; 210(259):698-700. PubMed ID: 4270841
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial.
    Gratton D; Raymond GP; Guertin-Larochelle S; Maddin SW; Leneck CM; Warner J; Collins JP; Gaudreau P; Bendl BJ
    J Am Acad Dermatol; 1982 Jul; 7(1):50-3. PubMed ID: 6213682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin for tetracycline-resistant acne.
    Basler RS
    Cutis; 1980 May; 25(5):527-8. PubMed ID: 6445814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative double blind study of topical clindamycine phosphate, oral tetracycline chlorhydrate and a placebo in the treatment of moderate to severe acne vulgaris].
    Guertin-Larochelle S; Raymond GP; Gratton D; Collins JP; Gaudreau P
    Union Med Can; 1982 Jun; 111(6):559-62. PubMed ID: 6214069
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical clindamycin in the control of acne vulgaris.
    Stoughton RB; Resh W
    Cutis; 1976 Mar; 17(3):551-4. PubMed ID: 138549
    [No Abstract]   [Full Text] [Related]  

  • 17. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
    Leyden JJ; Krochmal L; Yaroshinsky A
    J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
    NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
    Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
    Hjorth N; Schmidt H; Thomsen K; Dela K
    Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.